The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis
- PMID: 22472772
- DOI: 10.1177/0004867412443900
The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis
Abstract
Objective: To provide the most up-to-date prevalence estimates of alcohol and illicit drug use among individuals with psychosis in Australia, and explore correlates associated with a lifetime diagnosis of both alcohol abuse/dependence and cannabis abuse/dependence.
Method: This paper uses data from the Survey of High Impact Psychosis (SHIP), conducted as a follow-up to the first Australian National Low Prevalence (Psychotic) Disorders Study (1997-1998). The SHIP was a national study, carried out across five states, in which a sample of 1825 individuals was recruited through a two-phase sampling framework.
Results: Alcohol and illicit drug use was highly prevalent for the entire sample. There were few significant differences in the prevalence or frequency of use across the diagnostic categories examined. Substantial increases in substance abuse/dependence were noted since the 1997-1998 survey (51% diagnosed with alcohol abuse/dependence, 51% with cannabis abuse/dependence and 32% with other illicit drug abuse/dependence, compared to 28%, 23% and 12% respectively, in the 1997-1998 survey by Kavanagh et al., 2004). Factors significantly associated with both lifetime alcohol and cannabis dependence included male gender, younger age, single marital status, lower educational attainment, shorter duration of illness, lifetime presence of hallucinations, higher negative syndrome score and lower body mass index (BMI). A number of other factors were found to be differentially associated with either lifetime alcohol or cannabis dependence.
Conclusions: The use of alcohol and illicit substances is common among people with a psychotic illness, with a concerning upward trend in rates of substance abuse/dependence since the 1997-1998 survey. Clinicians should be aware of the potential impact of concurrent substance use and provide integrated treatment for individuals presenting with psychotic illnesses. More research and investment in new intervention programs is required.
Similar articles
-
[Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].Encephale. 2002 Mar-Apr;28(2):160-8. Encephale. 2002. PMID: 11972143 French.
-
Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis.Aust N Z J Psychiatry. 2012 Sep;46(9):851-63. doi: 10.1177/0004867412449876. Epub 2012 May 29. Aust N Z J Psychiatry. 2012. PMID: 22645396
-
People living with psychotic illness in 2010: the second Australian national survey of psychosis.Aust N Z J Psychiatry. 2012 Aug;46(8):735-52. doi: 10.1177/0004867412449877. Epub 2012 Jun 13. Aust N Z J Psychiatry. 2012. PMID: 22696547
-
Substance misuse and early psychosis.Australas Psychiatry. 2009 Aug;17(4):291-4. doi: 10.1080/10398560802657314. Australas Psychiatry. 2009. PMID: 19301164 Review.
-
Reasons for increased substance use in psychosis.Clin Psychol Rev. 2007 May;27(4):494-510. doi: 10.1016/j.cpr.2006.09.004. Epub 2007 Jan 19. Clin Psychol Rev. 2007. PMID: 17240501 Review.
Cited by
-
Psychosocial Factors Affecting Smoking Cessation Among People Living With Schizophrenia: A Lived Experience Lens.Front Psychiatry. 2019 Aug 15;10:565. doi: 10.3389/fpsyt.2019.00565. eCollection 2019. Front Psychiatry. 2019. PMID: 31474884 Free PMC article.
-
Who should be "controls" in studies on the neurobiology of psychiatric disorders?J Psychiatry Neurosci. 2018 Aug;43(5):292-297. doi: 10.1503/jpn.180128. J Psychiatry Neurosci. 2018. PMID: 30125246 Free PMC article. No abstract available.
-
Ten-year audit of clients presenting to a specialised service for young people experiencing or at increased risk for psychosis.BMC Psychiatry. 2014 Nov 18;14:318. doi: 10.1186/s12888-014-0318-4. BMC Psychiatry. 2014. PMID: 25403891 Free PMC article.
-
Supporting the vulnerable: developing a strategic community mental health response to the COVID-19 pandemic.Australas Psychiatry. 2020 Oct;28(5):492-499. doi: 10.1177/1039856220944701. Epub 2020 Jul 30. Australas Psychiatry. 2020. PMID: 32729320 Free PMC article.
-
Impact of substance use disorder on gray matter volume in schizophrenia.Psychiatry Res Neuroimaging. 2018 Oct 30;280:9-14. doi: 10.1016/j.pscychresns.2018.08.002. Epub 2018 Aug 3. Psychiatry Res Neuroimaging. 2018. PMID: 30121336 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical